![Joseph Luminiello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Luminiello
Algemeen Directeur bij Third Coast Therapeutics, Inc.
Profiel
Joseph Luminiello currently works at Ave Maria Biotechnology LLC, as Chief Executive Officer from 2021 and Third Coast Therapeutics, Inc., as Chief Executive Officer.
Actieve functies van Joseph Luminiello
Bedrijven | Functie | Begin |
---|---|---|
Third Coast Therapeutics, Inc.
![]() Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL. | Algemeen Directeur | - |
Ave Maria Biotechnology LLC
![]() Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Algemeen Directeur | 01-08-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Third Coast Therapeutics, Inc.
![]() Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL. | Health Technology |
Ave Maria Biotechnology LLC
![]() Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |